U.S. Sen. John Kennedy took to the Senate floor Tuesday to renew questions about the Biden Federal Communications Commission's approval of a deal for far-left activist financier George Soros to acquire more than 200 stations at once, declaring something 'weird' expedited the review that Trump's new FCC should investigate.
"GLP-3" breakthrough drug retatrutide by Eli Lilly shows major weight loss in clinical trials. The triple-agonist medication targets three hormones, with positive results....
Energy companies served federal wartime contracts in Louisiana 80 years ago, but now face $750 million award in coastal erosion lawsuit which deserves a fairer forum....